173 related articles for article (PubMed ID: 32706774)
1. Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
Vashistha V; Poonnen PJ; Snowdon JL; Skinner HG; McCaffrey V; Spector NL; Hintze B; Duffy JE; Weeraratne D; Jackson GP; Kelley MJ; Patel VL
PLoS One; 2020; 15(7):e0235861. PubMed ID: 32706774
[TBL] [Abstract][Full Text] [Related]
2. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
[TBL] [Abstract][Full Text] [Related]
3. Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.
Shirdarreh M; Aziza O; Pezo RC; Jerzak KJ; Warner E
Oncologist; 2021 Aug; 26(8):e1359-e1371. PubMed ID: 33823080
[TBL] [Abstract][Full Text] [Related]
4. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
Vashistha V; Armstrong J; Winski D; Poonnen PJ; Hintze B; Price M; Snowdon JL; Weeraratne D; Brotman D; Jackson GP; Kelley MJ
JCO Oncol Pract; 2021 Jul; 17(7):e1012-e1020. PubMed ID: 33780286
[TBL] [Abstract][Full Text] [Related]
5. Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now.
Scott A; Mohan A; Austin S; Amini E; Raupp S; Pannecouk B; Kelley MJ; Narla G; Ramnath N
JCO Oncol Pract; 2022 Jun; 18(6):e966-e973. PubMed ID: 35258993
[TBL] [Abstract][Full Text] [Related]
6. VA National Precision Oncology Program.
Kelley MJ
Fed Pract; 2020 Aug; 37(Suppl 4):S22-S27. PubMed ID: 32908351
[TBL] [Abstract][Full Text] [Related]
7. Involving patients and their families in deciding to use next generation sequencing: Results from a nationally representative survey of U.S. oncologists.
Spees LP; Roberts MC; Freedman AN; Butler EN; Klein WMP; Prabhu Das I; de Moor JS
Patient Educ Couns; 2021 Jan; 104(1):33-39. PubMed ID: 32197930
[TBL] [Abstract][Full Text] [Related]
8. Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey.
Shah-Manek B; Wong W; Ravelo A; DiBonaventura M
J Manag Care Spec Pharm; 2018 Jun; 24(6):565-571. PubMed ID: 29451078
[TBL] [Abstract][Full Text] [Related]
9. The Appropriate Provision of Primary versus Specialist Palliative Care to Cancer Patients: Oncologists' Perspectives.
Gidwani R; Nevedal A; Patel M; Blayney DW; Timko C; Ramchandran K; Kelly PA; Asch SM
J Palliat Med; 2017 Apr; 20(4):395-403. PubMed ID: 27997278
[TBL] [Abstract][Full Text] [Related]
10. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
[TBL] [Abstract][Full Text] [Related]
11. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
12. Trial of Electronic Medical Record Integrated Next-Generation Sequencing Ordering in Veterans Affairs Cancer Care.
Stoeckle JH; Poland SG; Maynard H; Roman SD; Mettman D; Makarov DV; Sherman S; Becker DJ
JCO Precis Oncol; 2024 Apr; 8():e2300463. PubMed ID: 38691812
[TBL] [Abstract][Full Text] [Related]
13. A Mixed-Methods Study of Veterans Affairs Providers' Experiences Communicating With Patients About the Affordable Care Act.
Martinez RN; Gordon EJ; Tully S; Silva A; Tarlov E; French DD; Huo Z; Smith BM; Gordon HS; Stroupe KT
Mil Med; 2017 May; 182(5):e1715-e1723. PubMed ID: 29087916
[TBL] [Abstract][Full Text] [Related]
14. Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
Anderson EC; Hinton AC; Lary CW; Fenton ATHR; Antov A; Edelman E; Helbig P; Reed K; Miesfeldt S; Thomas CA; Hall MJ; Roberts JS; Rueter J; Han PKJ;
BMC Cancer; 2021 Nov; 21(1):1273. PubMed ID: 34823486
[TBL] [Abstract][Full Text] [Related]
15. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer.
Minami CA; Bryan AF; Freedman RA; Revette AC; Schonberg MA; King TA; Mittendorf EA
JAMA Netw Open; 2022 Aug; 5(8):e2228524. PubMed ID: 36001314
[TBL] [Abstract][Full Text] [Related]
17. Understanding next generation sequencing in oncology: A guide for oncologists.
Moorcraft SY; Gonzalez D; Walker BA
Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
[TBL] [Abstract][Full Text] [Related]
18. Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions.
Yabroff KR; Sylvia Shi K; Zhao J; Freedman AN; Zheng Z; Nogueira L; Han X; Klabunde CN; de Moor JS
JCO Oncol Pract; 2024 Mar; 20(3):429-437. PubMed ID: 38194620
[TBL] [Abstract][Full Text] [Related]
19. Oncologists' attitudes toward KRAS testing: a multisite study.
Harris JN; Liljestrand P; Alexander GL; Goddard KA; Kauffman T; Kolevska T; McCarty C; O'Neill S; Pawloski P; Rahm A; Williams A; Somkin CP
Cancer Med; 2013 Dec; 2(6):881-8. PubMed ID: 24403261
[TBL] [Abstract][Full Text] [Related]
20. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
